MedTrace Logo

Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial

NCT07088328 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-07-28

No results posted yet for this study

Summary

The aim of this study is to determine the value of Pentoxifylline for nephroprotection in these neonates with perinatal asphyxia, using cystatin C, regional oxygenation measured near infrared spectroscopy and renal Doppler sonography.

Conditions

  • Hypoxic-Ischemic Encephalopathy
  • Neonatal Encephalopathy
  • Pentoxifylline Adverse Reaction

Interventions

DRUG

Pentoxifylline

Intravenous administration for 3 days

OTHER

placebo distilled water

Intravenous administration for 3 days

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Hour
Max Age
5 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-30
Primary Completion
2026-01-30
Completion
2026-03-02

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07088328 on ClinicalTrials.gov